Bimekizumab Safety in Patients with Psoriasis Achieving Complete Skin Clearance: 4-year Analysis from 5 Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s757, 2026. DOI: 10.25251/v6wwxw80. Disponível em: https://skin.dermsquared.com/skin/article/view/4086. Acesso em: 2 may. 2026.